Dr. Melissa E. Crowder, MD

Dr. Crowder practices at Renown Regional Medical Center in Reno, Nevada, part of Renown Health.

Dr. Crowder's NPI, 1902251820, was assigned on April 28, 2016. Dr. Crowder graduated from Tulane School of Medicine in 2016. Dr. Crowder's Nevada license number on file is 23182.

Dr. Crowder's primary practice is Renown Regional Medical Center, at 1155 Mill Street, Reno, NV 89502 in Washoe County. The practice phone is (775) 982-4100.

Dr. Crowder's primary practice is Renown Regional Medical Center in Reno, Nevada, part of Renown Health. Dr. Crowder is also affiliated with Renown South Meadows Medical Center. The medical group on file is Renown Health. Dmand AI also links Dr. Crowder to 3 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Crowder practices, 6 sites in all. Vendor and product names are available with a free account.

Epilepsy is Dr. Crowder's primary specialty in the NPI Registry, under taxonomy code 2084E0001X. Dr. Crowder is board certified in epilepsy by the American Board of Psychiatry and Neurology. Dmand AI has Dr. Crowder's licenses on file in 3 states: Nevada, New Hampshire and Vermont.

Dmand AI lists acute mini-stroke (TIA), epilepsy, fibromyalgia and chronic pain, migraine and chronic headache, nerve damage and seizures among the conditions Dr. Crowder treats.

CMS data shows 393 Medicare services from Dr. Crowder across 11 procedure codes in 2024, for 206 Medicare patients. Medicare paid $32,280 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 206 Medicare patients who saw Dr. Crowder in 2024. The largest group is 65 to 74, with 74 patients. 73% of them have high cholesterol, and 66% have high blood pressure. 35% are also on Medicaid. Their average risk score is 1.80, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Crowder's median patient age at 67, with 42% women.

In 2024, Dr. Crowder wrote 776 Medicare Part D claims for 139 patients. 90% of them were for generic drugs. CMS names the drug for 656 of them, across 20 drugs with 11 or more claims each, at $121,731 in total drug cost. In 2023, CMS named 241 claims across 12 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 85 out of 100 for Dr. Crowder for performance year 2024, reported as part of a group. Dr. Crowder accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Crowder as offering telehealth.

Dmand AI links 3 papers to Dr. Crowder in 2020. The most frequent topics are Motor Neurons, Muscular Atrophy, Spinal and Synapses. Dr. Crowder's most frequent co-authors are Charlotte J. Sumner, MD, Thomas Owen Crawford, MD and Mark Rich, MD, PhD.

CMS Open Payments shows 2 general payments to Dr. Crowder from 2 drug and device companies in 2023. Food and beverage make up the largest share, 100% of the total. Neuropace, Inc. paid the most, $43.

Dr. Crowder graduated from Tulane School of Medicine in 2016.

Dr. Crowder is in network with 11 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. HMO plans come from the most carriers, 6. Check the plan with the practice before a visit.